BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 3968450)

  • 41. Immunological responses of rabbits to various somatic and secreted antigens of Vibrio cholerae after intra-duodenal inoculation.
    Kabir S
    J Med Microbiol; 1987 Aug; 24(1):29-40. PubMed ID: 3612742
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Field trial of oral cholera vaccines in Bangladesh: evaluation of anti-bacterial and anti-toxic breast-milk immunity in response to ingestion of the vaccines.
    Clemens JD; Sack DA; Chakraborty J; Rao MR; Ahmed F; Harris JR; van Loon F; Khan MR; Yunis M; Huda S
    Vaccine; 1990 Oct; 8(5):469-72. PubMed ID: 2251873
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vibrio cholerae Sialidase-Specific Immune Responses Are Associated with Protection against Cholera.
    Kaisar MH; Bhuiyan MS; Akter A; Saleem D; Iyer AS; Dash P; Hakim A; Chowdhury F; Khan AI; Calderwood SB; Harris JB; Ryan ET; Qadri F; Charles RC; Bhuiyan TR
    mSphere; 2021 Apr; 6(2):. PubMed ID: 33910997
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vibriocidal titre in cholera cases and contacts: its value in assessing endemicity of or susceptibility to cholera.
    Khan MU; Barua DK; Begum T; Shahidullah M
    Trop Geogr Med; 1987 Jul; 39(3):271-5. PubMed ID: 3433343
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Study of avidity of antigen-specific antibody as a means of understanding development of long-term immunological memory after Vibrio cholerae O1 infection.
    Alam MM; Arifuzzaman M; Ahmad SM; Hosen MI; Rahman MA; Rashu R; Sheikh A; Ryan ET; Calderwood SB; Qadri F
    Clin Vaccine Immunol; 2013 Jan; 20(1):17-23. PubMed ID: 23114701
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vibrio cholerae O1 vibriocidal and anti-cholera toxin antibodies in O139 Bengal cholera patients.
    Takeda T; Ramamurthy T; Chowdhury AS; Dutta D; Bhattacharya SK; Deb BC; Nair GB; Takeda Y
    J Infect; 1994 Sep; 29(2):233-5. PubMed ID: 7806891
    [No Abstract]   [Full Text] [Related]  

  • 47. Mucosal antitoxic and antibacterial immunity after cholera disease and after immunization with a combined B subunit-whole cell vaccine.
    Svennerholm AM; Jertborn M; Gothefors L; Karim AM; Sack DA; Holmgren J
    J Infect Dis; 1984 Jun; 149(6):884-93. PubMed ID: 6736680
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immune response to the mannose-sensitive hemagglutinin in patients with cholera due to Vibrio cholerae O1 and O0139.
    Qadri F; Jonson G; Begum YA; Wennerås C; Albert MJ; Salam MA; Svennerholm AM
    Clin Diagn Lab Immunol; 1997 Jul; 4(4):429-34. PubMed ID: 9220159
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-Term Kinetics of Serological Antibodies against
    Muzembo BA; Kitahara K; Mitra D; Ohno A; Miyoshi SI
    Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742404
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Single-Cell Analysis of the Plasmablast Response to Vibrio cholerae Demonstrates Expansion of Cross-Reactive Memory B Cells.
    Kauffman RC; Bhuiyan TR; Nakajima R; Mayo-Smith LM; Rashu R; Hoq MR; Chowdhury F; Khan AI; Rahman A; Bhaumik SK; Harris L; O'Neal JT; Trost JF; Alam NH; Jasinskas A; Dotsey E; Kelly M; Charles RC; Xu P; Kováč P; Calderwood SB; Ryan ET; Felgner PL; Qadri F; Wrammert J; Harris JB
    mBio; 2016 Dec; 7(6):. PubMed ID: 27999163
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transcriptional profiling of Vibrio cholerae O1 following exposure to human anti- lipopolysaccharide monoclonal antibodies.
    Baranova DE; Willsey GG; Levinson KJ; Smith C; Wade J; Mantis NJ
    Pathog Dis; 2020 Jun; 78(4):. PubMed ID: 32589220
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae O1 serotype Inaba bound to cholera toxin.
    Gupta RK; Szu SC; Finkelstein RA; Robbins JB
    Infect Immun; 1992 Aug; 60(8):3201-8. PubMed ID: 1639490
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antitoxic immunity in experimental cholera: protection, and serum and local antibody responses in rabbits after enteral and parenteral immunization.
    Holmgren J; Svennerholm AM; Ouchterlony O; Anderson A; Walletström G; Westerberg-Berndtsson U
    Infect Immun; 1975 Dec; 12(6):1331-40. PubMed ID: 54337
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Strong biotype and serotype cross-protective antibacterial and antitoxic immunity in rabbits after cholera infection.
    Lycke N; Svennerholm AM; Holmgren J
    Microb Pathog; 1986 Aug; 1(4):361-71. PubMed ID: 3508492
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Large epidemic of cholera-like disease in Bangladesh caused by Vibrio cholerae O139 synonym Bengal. Cholera Working Group, International Centre for Diarrhoeal Diseases Research, Bangladesh.
    Lancet; 1993 Aug; 342(8868):387-90. PubMed ID: 8101899
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cholera toxin-specific memory B cell responses are induced in patients with dehydrating diarrhea caused by Vibrio cholerae O1.
    Jayasekera CR; Harris JB; Bhuiyan S; Chowdhury F; Khan AI; Faruque AS; Larocque RC; Ryan ET; Ahmed R; Qadri F; Calderwood SB
    J Infect Dis; 2008 Oct; 198(7):1055-61. PubMed ID: 18729782
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Humans Surviving Cholera Develop Antibodies against Vibrio cholerae O-Specific Polysaccharide That Inhibit Pathogen Motility.
    Charles RC; Kelly M; Tam JM; Akter A; Hossain M; Islam K; Biswas R; Kamruzzaman M; Chowdhury F; Khan AI; Leung DT; Weil A; LaRocque RC; Bhuiyan TR; Rahman A; Mayo-Smith LM; Becker RL; Vyas JM; Faherty CS; Nickerson KP; Giffen S; Ritter AS; Waldor MK; Xu P; Kováč P; Calderwood SB; Kauffman RC; Wrammert J; Qadri F; Harris JB; Ryan ET
    mBio; 2020 Nov; 11(6):. PubMed ID: 33203761
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Correlates of Protection for Cholera.
    Iyer AS; Harris JB
    J Infect Dis; 2021 Dec; 224(12 Suppl 2):S732-S737. PubMed ID: 34668561
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transcutaneous immunization with toxin-coregulated pilin A induces protective immunity against Vibrio cholerae O1 El Tor challenge in mice.
    Rollenhagen JE; Kalsy A; Cerda F; John M; Harris JB; Larocque RC; Qadri F; Calderwood SB; Taylor RK; Ryan ET
    Infect Immun; 2006 Oct; 74(10):5834-9. PubMed ID: 16988262
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Local production of anti-vibrio cholerae mucosal antibody in reproductive tract tissues after cholera.
    Ryan ET; Bridges EA; Crean TI; Gausia K; Hamadani JD; Aziz A; Hawkes S; Begum M; Bogaerts J; Faruque SM; Salam MA; Fuchs GJ; Calderwood SB
    J Infect Dis; 2001 Sep; 184(5):643-7. PubMed ID: 11494170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.